Head & Neck · 2015 · 13 citations · 22 references
MedicineOncologyOral PathologyMetastasisMolecular OncologyOral OncologyAngiogenesis In Oral CancerOral Cancer BiomarkersOral Cancer MetastasisOral Cavity CancerOral NeoplasiaSquamous Cell CarcinomaBiomarker-based Risk PredictionDisease-specific SurvivalDistant Nodal MetastasisImmunohistochemical BiomarkersImmunohistochemical DetectionImmunohistochemical MarkersLymph Node Metastasis PrognosisVascular Endothelial Growth Factor
BACKGROUND: The purpose of this study was to evaluate the clinical usefulness of the immunoexpression of Ki-67, matrix metalloproteinase (MMP)-2, MMP-9, vascular endothelial growth factor (VEGF)-C, and VEGF-D in predicting follow-up treatment in patients with squamous cell carcinoma (SCC) of the tongue and floor of the mouth (FOM). METHODS: Marker expression was evaluated in surgical specimens taken from 60 patients who underwent surgery because of primary SCC without prior therapy. RESULTS: Strong MMP-2 expression was positively correlated with a higher risk of nodal recurrence (p = .047). Strong VEGF-C expression was found in patients with distant metastases (p = .008). Cox's regression model showed high Ki-67, MMP-2, and VEGF-C expression, which were independent predictors of disease-specific survival (p = .001, p = .002, and p < .001, respectively). CONCLUSION: It seems that targeting MMP-2 and VEGF-C may improve local control, thereby reducing the risk of distant metastasis in patients with SCC of the tongue and FOM. © 2015 Wiley Periodicals, Inc. Head Neck 38: E747-E753, 2016.
22
Expression of vascular endothelial growth factor A, B, C, and D in oral squamous cell carcinoma
Satoru Shintani, Chunnan Li, Tohru Ishikawa et al. · Oral Oncology · 2003 · 131 citations
Medicine, Cancer Biology, Oncology +14